Why is tivicay so expensive?

Short answer: mainly because Tivicay is a brand-name, patented HIV medicine with limited competition in many markets, plus the general way US drug prices are set (high list price, with discounts and rebates managed behind the scenes). Other factors include R&D and manufacturing costs, and the value insurers place on a highly effective, tolerable drug.

Key factors in price
- Patent protection and exclusivity: Generics aren’t (or aren’t widely) available in some markets yet, so there’s less competition to push prices down.
- R&D and regulatory costs: The cost of discovering, testing, and getting approval for a new HIV drug is very high, and manufacturers price to recoup those investments.
- Pricing and rebates in the US: The list price may be high, but many patients pay less due to insurance contracts, formularies, and negotiated rebates. Your out-of-pocket depends on your plan, deductible, and whether the drug is on your formulary.
- Global differences: Other countries with generic dolutegravir or different pricing rules can have much lower costs.

Ways to manage cost
- Check if a generic dolutegravir option is available in your country (or if a generics market is accessible) and ask your clinician about alternatives if appropriate.
- Ask about patient assistance programs: ViiV Healthcare (the maker) often has programs to help with access; your clinic social worker or pharmacist can help apply.
- Use insurance tools and discount cards: Compare your pharmacy’s copay with manufacturer programs, and ask about GoodRx or local discount programs.
- Explore alternatives with your clinician: Some regimens include generic components or different medicines that may be cheaper while still effective for you.
- If cost is a barrier, never stop or change HIV treatment without medical guidance. Contact your healthcare team for safer options.

If you tell me your country and whether you have insurance, I can help you think through likely out-of-pocket ranges and specific cost-saving options available to you.